Epiphany

epic oncology™

 
epic oncology™
Comprehensive Coverage
THIS HAS TO CHANGE!!!!
epic oncology™ is the most comprehensive cancer epidemiology source available with detailed and forecasted statistics. No other commercially-available dataset offers the depth and breadth of the epic oncology™ dataset.

Comprehensive Coverage

Epiphany’s detailed cancer epidemiology service includes the following countries for the 2015 subscription year:

Global Coverage

AMERICAS   EUROPE, MIDDLE EAST, AFRICA ASIA  
United States  France Japan 
Argentina  Germany  Australia
Brazil  Italy  China
Canada  Spain  India
Mexico  United Kingdom South Korea
  Netherlands Taiwan
  Poland  
  Russia  
  South Africa  
  Turkey  

epic oncology™ Cancer Listing

epic oncology™ also contains 38 cancers with 90 key histological or mutation subsets as well as detailed staging and age-group analyses. The following is a listing of the cancers, subsets, and biomarkers/special analyses available in the 2015 dataset:

TOTAL CANCERS
Cancer
38
Subsets
90
Staging
149
Biomarkers
375
Cancers Subsets Staging Biomarkers
All Sites
AJCC: I, II, III, IV
Brain Glioblastoma
Anaplastic
Low Grade

PTEN 
Breast HR(+)/HER2(+)
HR(+)/HER2(-)
HR(-)/HER2(+)
HR(-)/HER2(-)
AJCC: IA/B, IIA/B,
IIIA/B/C, IV
BRCA1
BRCA2
PTEN
Melanoma
AJCC: I, II, IIIA/B/C, IV  BRAF, NRAS, PTEN
Thyroid Follicular
Papillary
Medullary
Anaplastic
Other
AJCC: I, II, III, IV
GASTROINTESTINAL (GI) CANCERS
Cancers Subsets Staging Biomarkers
Biliary Tract Gallbladder
Cholangiocarcinoma
Other
AJCC: I, II, III, IV
Colon
Rectum

AJCC: I, II, III, IV
KRAS, BRAF
dMMR (MSI)
PTEN
Esophageal
Adenocarcinoma
Squamous Cell
Other
AJCC: I, II, III, IV
HER2
Gastric

AJCC: I, II, III, IV
HER2
Liver* Hepatocellular (HCC)
Other
AJCC: I, II, IIIA/B/C, IVA/B
Pancreatic Adenocarcinoma
PNET
AJCC: I, II, III, IV PTEN
GENITOURINARY (GU) CANCERS
Cancers Subsets Staging Biomarkers
Bladder
AJCC: 0a, 0is, I, II, III, IV
Prostate Hormone Sensitive
Castrate Resistant
AJCC: I, II, III, IV PTEN
Renal Cell§ Clear Cell
Non-Clear Cell
AJCC: I, II, III, IV
GYNECOLOGICAL (GYN) CANCERS
Cancers Subsets Staging Biomarkers
Cervical
AJCC: I, II, III, IV

Ovarian Serous
Mucinous
Endometroid
Clear Cell
Other
AJCC: I, II, III, IV BRCA1
BRCA2
PTEN
Uterine
AJCC: I, II, III, IV
PTEN
HEAD AND NECK (HNC) CANCERS
Cancers Subsets Staging Biomarkers
Larynx
Oral Cavity
Oropharynx
Other Pharynx
Nasal Cavity & Sinus
Squamous Cell
Non-Squamous
AJCC: I, II, III, IVA/B/C
HEMATOLOGIC (HEME) MALIGNANCIES
Cancers Subsets Staging Biomarkers
Leukemia, Acute Lymphoblastic (ALL) Philadelphia Positive
Philadelphia Negative


Leukemia, Acute Myeloid (AML)
AML
APL
NPM1, FLT3-ITD, CEBPA
Leukemia, Chronic Lymphocytic (CLL)

Rai: 0, I, II, III, IV
Leukemia, Chronic Myelogenous (CML)
Chronic
Accelerated
Blast Crisis
Hodgkin's Lymphoma (HL)

AJCC: I, II, III, IV
Non-Hodgkin's Lymphoma (NHL)
Follicular (Gr1/2)
Other B-cell Indolent
Cell Type: B-cell, Indolent
Transformed Lymphoma
(Indolent B-cell to DLBCL)
Follicular (Gr3)
Mantle Cell
Diffuse Large B-cell (DLBCL)
Other B-cell Aggressive
Cell Type: B-cell, Aggressive
Cutaneous T-cell (CTCL)
Other T-cell Indolent
Cell Type: T-cell, Indolent
Peripheral T-cell (PTCL)
Other T-cell Aggressive
Cell Type: T-cell, Aggressive
Multiple Myeloma
Transplant Eligible
Transplant Ineligible
ISS: I, II, III
Myelodysplastic Syndromes (MDS)
WHO Subsets
FAB Subsets
IPSS: Low, Int-1, Int-2, High 
Myeloproliferative Neoplasms (MPN)
Polycythemia vera (PCV)
Essential Thrombocytosis (ET)
Myelofibrosis (MF)

JAK2
RESPIRATORY (RESP) CANCERS
Cancers Subsets Staging Biomarkers
Lung, Non-Small Cell Adenocarcinoma
Squamous Cell
Large Cell
Other
AJCC: I, II, IIIA/B, IV KRAS
EGFR
EGFR Copy
ALK
Lung, Small Cell
AJCC: I, II, III, IV
Limited/Extensive
SARCOMAS (SARC)
Cancers Subsets Staging Biomarkers
Gastrointestinal Stromal Tumors (GIST) Gastric
Small Intestine
Other
AJCC: I, II, III, IV
Mesothelioma
AJCC: I, II, III, IV
Osteosarcoma Osteosarcoma
Chondrosarcoma
Ewing's sarcoma
Other
AJCC: I, II, III, IV
Soft Tissue Sarcoma Fibrohistiocytoma
Liposarcoma
Leiomyosarcoma
Rhabdomyosarcoma
Other
AJCC: I, II, III, IV
* Liver data is available by multiple staging systems (AJCC, BCLC, CLIP, JIS, Child-Pugh)
§ Renal cell cancer is defined as just "Kidney" and excludes "Renal Pelvis"
Epiphany Partners, Inc.
1900 South Norfolk Street, Suite 260
San Mateo, California 94403
Main 650-242-4626
Fax 650-288-0036
info@time4epi.com 
Driving Directions
Follow us: LinkedIn
©2013 Copyright Epiphany Partners, Inc.  •  Terms of Use  •  Privacy Policy  •  Site Map